Health care resource utilization and clinical outcomes for adult heart transplant recipients with primary graft dysfunction
Clinical Transplantation · 2023
DOI: 10.1111/ctr.15048 ↗At a glance
Journal article in Clinical Transplantation, 2023. Written by Sharon L McCartney and 6 co-authors. Institution: Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA. Major MEDLINE topics: Heart Transplantation, Primary Graft Dysfunction, Patient Acceptance of Health Care, Health Resources. Cited 4 times so far (Crossref); 13 references.
Abstract (original language)
Introduction
The advent of new technologies to reduce primary graft dysfunction (PGD) and improve outcomes after heart transplantation are costly. Adoption of these technologies requires a better understanding of health care utilization, specifically the costs related to PGD.
Methods
Records were examined from all adult patients who underwent orthotopic heart transplantation (OHT) between July 1, 2013 and July 30, 2019 at a single institution. Total costs were categorized into variable, fixed, direct, and indirect costs. Patient costs from time of transplantation to hospital discharge were transformed with the z‐score transformation and modeled in a linear regression model, adjusted for potential confounders and in‐hospital mortality. The quintile of patient costs was modeled using a proportional odds model, adjusted for confounders and in‐hospital mortality.
Results
359 patients were analyzed, including 142 with PGD and 217 without PGD. PGD was associated with a .42 increase in z‐score of total patient costs (95% CI: .22‐.62; p < .0001). Additionally, any grade of PGD was associated with a 2.95 increase in odds for a higher cost of transplant (95% CI: 1.94‐4.46, p < .0001). These differences were substantially greater when PGD was categorized as severe. Similar results were obtained for fixed, variable, direct, and indirect costs.
Conclusions
PGD after OHT impacts morbidity, mortality, and health care utilization. We found that PGD after OHT results in a significant increase in total patient costs. This increase was substantially higher if the PGD was severe. Summary Primary graft dysfunction after heart transplantation impacts morbidity, mortality, and health care utilization. PGD after OHT is costly and investments should be made to reduce the burden of PGD after OHT to improve patient outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.
- Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
- Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
- Department of Medicine and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
ORCID profiles: Adam D DeVore, Alina Nicoara
Cite
APA
McCartney, S. L., Peskoe, S., Wright, M. C., Mamoun, N., Schroder, J. N., DeVore, A. D., & Nicoara, A. (2023). Health care resource utilization and clinical outcomes for adult heart transplant recipients with primary graft dysfunction. Clinical Transplantation. https://doi.org/10.1111/ctr.15048
Vancouver
McCartney SL, Peskoe S, Wright MC, Mamoun N, Schroder JN, DeVore AD, et al. Health care resource utilization and clinical outcomes for adult heart transplant recipients with primary graft dysfunction. Clinical Transplantation. 2023. doi:10.1111/ctr.15048
BibTeX
@article{McCartney2023,
author = {McCartney, Sharon L and Peskoe, Sarah and Wright, Mary Cooter and Mamoun, Negmeldeen and Schroder, Jacob N and DeVore, Adam D and Nicoara, Alina},
title = {Health care resource utilization and clinical outcomes for adult heart transplant recipients with primary graft dysfunction},
journal = {Clinical Transplantation},
year = {2023},
doi = {10.1111/ctr.15048}
}
EUVIMED